BWT Market Strategy

  • In 2016, BWT is expected to produce the Meningitis vaccine. A compulsory requirement for Hajj and Umrah pilgrims.
  • Potential market for Meningitis vaccines is projected to be USD30 million for South East Asia.
  • In 2018, BWT is expected to manufacture peadiatric combination vaccines.
  • The Fill and Finish facility will also be expanded for recombinant proteins.

The Muslim Population


Source: The future of world religions: population growth projections,2010-2050 Pew Research Center


  • World Muslim population in 2014 is 2.08 billion and constitutes the world’s second largest religion. Indonesia has 219 million Muslims, the highest in South East Asia.
  • The global vaccines market is expected to reach USD 57.8 billion by 2019, from USD 33.1 billion in 2014, at a CAGR of 11.8%. The largest market share is the paediatric vaccines. In 2010, sales of paediatric vaccines is USD2.6 billion. Growth in this segment is attributed to the rising prevalence of diseases and the increasing number of initiatives taken by government organizations for vaccination programs.
  • The global Halal vaccine market is estimated at USD 1.1 billion in 2030 which is approximately 3% of the total global preventive vaccine market. The market potential for halal vaccinations is dependent on the willingness of Muslims to accept them, especially in developing countries where the buyers, the government agencies, are not the end consumers. Most of these countries are supplied through global bodies-WHO.
  • The cycle of development of halal vaccines are long and costly. The challenge is to have these vaccines be within affordability, and accessibility to the end consumers.
  • Nevertheless, the intiatives for halal vaccines has to start with a few vaccines to cater for the rising Muslim population which is expected to increase by 35% in 2050 and surpassing the Christians by 2070.


Vaccines segments


  • Diseases preventable by vaccines: Meningitis cause by Neisseria meningitides.
  • Neisseria meningitides is one of the leading causes of bacterial meningitides globally. There are 12 serogroups, but majority of invasive meningococcal infections are caused by serogroups A,B,C,X,Y and W135. Worldwide invasive meningococcal infections are estimated to be at least 1.2 million with 135,000 deaths and 11-19% of survivors suffer permanent neurological disability ie, brain damage and hearing loss. About 10% of the population are asymptomatic carriers with the bacteria resides in their nostrils or at the back of their throat.
  • Conjugated vaccines for Meningitis ACYW135-protect against Neisseria meningitides infection. Mandatory for those going for Hajj and Umrah as part of visa requirement to Saudi.